Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Good product overall
In the NNMT literature it appears as 5-amino-1MQ, 5A-1MQ, or NNMTi when referring to the selective, substrate-site-targeting inhibitor series
Its just about risk. Eric Topol: Yeah
What this means for you right now: BPC-157 and TB-500 are currently available through licensed compounding pharmacies under clinician supervision Thymosin Alpha-1 has a longer regulatory history and a more established compounding track record Sourcing from unregulated vendors carries real safety risks contamination, misdosing, and no quality control We've covered the full regulatory picture in detail here: PCAC Peptide Review 2026: What the July Advisory Panel Decision Means for BPC-157, TB-500, and Thymosin Alpha-1 What a Clinician-Supervised Long COVID Peptide Protocol Looks Like A responsible protocol starts with assessment not assumption
US$ 22.94
US$ 23.92
US$ 23.36
US$ 20.09
US$ 25.96